Tag: Roche
Packaging pioneer Gerhard Schubert passes away at 84
Gerhard Schubert, the founder and shareholder of leading packaging machine manufacturer Schubert, passed away in Crailsheim on 4 July 2023 at the age of...
FDA admits Roche’s application for Polivy in lymphoma treatment
The United States Food and Drug Administration (FDA) has accepted the supplemental biologics license application(sBLA) by Roche, a Swiss multinational healthcare company, for the...
Roche launches Ventana DP 600 slide scanner for digital pathology
Cancer accounted for more than 10 million deaths in 2020 and is considered the leading cause of death worldwide. However, if identified early and...
Roche & Atea Pharmaceuticals collaborate to develop oral treatment for Covid-19...
Roche and Atea Pharmaceuticals announced that they are joining forces in the fight against Covid-19 to develop, manufacture and distribute AT-527, Atea's investigational oral...
Roche to launch SARS-CoV-2 Rapid Antigen Test in countries accepting CE...
Roche announced that it would launch a SARS-CoV-2 Rapid Antigen Test, in late September, for markets accepting the CE Mark. Roche also intends to...
Roche’s Elecsys IL-6 test receives FDA EUA to identify Covid-19 patients...
Roche announced that the US Food and Drug Administration (FDA) has issued an Emergency Use Authorisation (EUA) for the Elecsys IL-6 test. This test...
Covid-19 vaccine – When will we have it?
The recognized Covid-19 cases have surpassed 6.3 million globally and continue to grow. While the world is eagerly waiting for the coronavirus vaccine, research...
Roche initiates phase III clinical trial of Actemra, RoActemra and remdesivir
Roche announced the initiation of a global phase III, randomized, double-blind, multicenter study (REMDACTA) to evaluate the safety and efficacy of Actemra, RoActemra, and...
Roche develops new serology test to detect COVID-19 antibodies
Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to the...
Roche announces Venclexta or Venclyxto combination improved overall survival in people...
Roche has recently announced that the phase III VIALE-A study met its dual primary endpoints of overall survival and composite complete remission rate (CR...